Predicting the future of genomics
An interview with the Sanger Institute’s new director, Matt Hurles.
Empowering microbiome research in underrepresented countries
Mentoring and training early career scientists; building technology that can adapt to humid and hotter countries; finding a way of transporting anaerobic microorganisms. The pathway to accelerating microbiome research isn’t lacking challenges.
A representative reference genome
The human reference genome is the foundation of modern human genetics and genomics, underpinning most research into human health and disease. But, it has limitations - it doesn't reflect human genetic diversity. A new, pangenome reference has now been published, aiming to better represent humanity.
World Malaria Day 2023: Investing, innovating, and implementing genomic surveillance
Every year on April 25th, we observe World Malaria Day to raise awareness and mobilise action against malaria. This year, the World Health Organisation’s call to action focuses on three key areas: investing in the global malaria response, stepping up innovation, and implementing the strategies we have now.
A defining moment for cholera control
Using genomics to identify the exact strains of bacteria responsible for cholera outbreaks has overturned centuries of thought about the very nature of the disease. Integrating genomics into cholera surveillance efforts will be vital to track and ultimately end the current pandemic, as well as reduce the threat of future ones.
Building a bioinformatics community to tackle genomic questions at scale
Over 60 bioinformaticians and developers from across the Sanger Institute and EMBL’s European Bioinformatics Institute came together to take part in this nf-core hackathon to more easily share and analyse genomes.
African researchers training to develop large-scale genomics projects
As the science of genomics becomes ever more sophisticated, global capacity-sharing has never been more important.
Accidental Entrepreneur
In this third part of our innovator blog series, we spoke to Matt Hurles, Head of the Human Genetics programme and incoming Director of the Wellcome Sanger Institute. Matt defines himself as an accidental entrepreneur, even though he spearheads a number of innovative initiatives that showcase his motivation to ultimately bring benefits to patients.
Cholera and syphilis captured in BioArt
How historical artefacts can highlight the progression of science and medicine.
